Document Detail

Suppression of ventricular premature contractions possibly related to triggered activity by oral diltiazem and atenolol.
MedLine Citation:
PMID:  2439719     Owner:  NLM     Status:  MEDLINE    
The clinical importance of triggered activity as a cause of arrhythmias is uncertain. We assumed that ventricular premature contractions (VPCs) caused by triggered activity could be increased at higher heart rates and be suppressed by calcium channel blockers and beta-adrenoceptor blocker. Thus, we evaluated VPC frequency as a function of underlying heart rate and examined the efficacy of diltiazem and atenolol on VPCs, using 24 hour ECG recording. Plots of VPC frequency vs. heart rate were made at 1-beat/min intervals for all heart rates recorded for at least 5 min during 24 hours. Diltiazem (90-180 mg/day) and atenolol (50 mg/day) were given orally for 4 weeks, respectively in 36 and 16 patients with VPCs of more than 2000/day. Patterns of relationship between VPC frequency and heart rate observed before diltiazem therapy included: an increase of VPCs at higher heart rates (positive correlation) in 16 patients, an increase at low heart rates and a decrease at high heart rates (bidirectional correlation) in 13 patients, an increase at low heart rates and flat curve at high heart rates (positive-flat correlation) in 5 patients, a linear decrease (negative correlation) in 1 patient, and flat curve (flat correlation) in 1 patient. The patterns of correlation in patients treated with atenolol were positive in 6, bidirectional in 7, positive-flat in 2 and negative in 1. Both drugs significantly reduced the VPC frequency per 24 hours for patients with a positive correlation (P group), but induced no significant change for those with the other patterns of correlation (NP group). At the 70% VPC suppression level, diltiazem was effective in 9 of 16 patients of P group and only 1 of 20 patients of NP group (p less than 0.01); atenolol was effective in 5 of 6 patients of P group and only 1 of 10 patients of NP group (p less than 0.05). Both drugs reduced the slope of a positive correlation. These results suggest that: VPCs which increase at higher heart rates may be related to triggered activity, and an evaluation of VPC frequency as a function of heart rate predicts the response of VPCs to diltiazem and atenolol, and probably to other calcium antagonists and beta blockers.
M Ito; S Tsumabuki; Y Maeda; M Arita; T Saikawa; S Ito; T Fujino; T Fukumoto; K Yamada; Y Kikuchi
Related Documents :
25119289 - Longitudinal hemodynamic measurements in swine heart failure using a fully implantable ...
1480509 - Effects of pituitary adenylate cyclase activating polypeptide (pacap) and vasoactive in...
23114199 - The mechanics of left ventricular filling during the strain phase of the valsalva maneu...
4092369 - Continuous 24-hour intra-arterial blood pressure recording in the conscious unrestraine...
23379389 - A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat.
16600449 - Magnitude of cerebral asymmetry at rest: covariation with baseline cardiovascular activ...
22034939 - Exposure to road traffic and railway noise and associations with blood pressure and sel...
2022219 - Fluid delivery systems: high flow, low pressure, the key to safe resection.
11153049 - Determination of ambulatory blood pressure control in treated patients with controlled ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Japanese circulation journal     Volume:  51     ISSN:  0047-1828     ISO Abbreviation:  Jpn. Circ. J.     Publication Date:  1987 Feb 
Date Detail:
Created Date:  1987-08-04     Completed Date:  1987-08-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7806868     Medline TA:  Jpn Circ J     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  217-29     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Atenolol / therapeutic use*
Cardiac Complexes, Premature / drug therapy*,  etiology
Diltiazem / therapeutic use*
Heart Rate
Middle Aged
Monitoring, Physiologic
Reg. No./Substance:
29122-68-7/Atenolol; 42399-41-7/Diltiazem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The daily profile of ventricular premature beats in the patients with ischemic heart disease.
Next Document:  The clinical evaluation of the late potentials in patients with ventricular arrhythmias.